Imaxeon Research and Development
Imaxeon’s development team has been responsible for 4 generations of contrast injectors,
starting with the PJ series of CT injectors which coupled low pricing with ease of use. Subsequent generations include
an angio injector and more recently the Salient CT Injector.
The internal development processes are audited annually for compliance with ISO13485, and
are appropriate to Class IIa, IIb and lower risk medical devices. Imaxeon has also developed several successful syringe
lines to accompany these injectors. The cross-disciplinary team is small but able to focus on delivering cohesive